Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC.SI · Entity 5607 | Director | June 26, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SHOULDER INNOVATIONS, INC.
Report date June 26, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,712 |
Reported balance
After 2026-06-26 transaction · row 1
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 5,046 · Balance 18,712 F1: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Inspire Medical Systems, Inc.
Report date February 13, 2026 · Filed February 18, 2026
Section 16 reporting ended · disclosed 2026-02-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,988 |
Reported balance
After 2026-02-13 transaction · row 1
1 source rowRow 1 · 2026-02-13 · Tax withholding · Disposed 579 · Balance 43,988 F1: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 1,475 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,475 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 1,475 |
Reported balance
Holding disclosure · report date 2026-02-13 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,475 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 376 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · derivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376 Underlying: Common Stock · 376 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 6,015 underlying shares on January 1, 2018 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 5,494 | $42.15 | $231,572.10 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,410 | $10.38 | $14,635.80 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 987 | $0.94 | $927.78 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:00 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 376 | $0.94 | $353.44 |
DisclosureSEC source: 0001104659-20-114217 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,200 | $122.75 | $147,300.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.73 to $122.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 600 | $123.65 | $74,190.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,584 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.16 to $123.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 700 | $125.01 | $87,507.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,184 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.53 to $125.25. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $126.01 | $63,005.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,884 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.70 to $126.33. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,900 | $127.55 | $242,345.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.13 to $128.07. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 600 | $128.64 | $77,184.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,284 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.28 to $129.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 500 | $130.05 | $65,025.00 |
DisclosureSEC source: 0001104659-20-108314 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,884 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.52 to $130.49. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,952 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · derivative · entry 19 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,048 Underlying: Common Stock · 1,952 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on December 18, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,687 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · derivative · entry 18 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,869 Underlying: Common Stock · 12,687 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on April 9, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F12 · derivative.expiration_date: This option grant was previously reported as having an expiration date of April 8, 2028, which has been revised herein. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,706 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · derivative · entry 17 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,706 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F6 · derivative.expiration_date: This option grant was previously reported as having an expiration date of May 31, 2024, which has been revised herein. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,628 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · derivative · entry 16 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,215 Underlying: Common Stock · 3,628 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on April 1, 2018 and has vested or will vest and become exercisable with respect to the remaining 75% of the award in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F10 · derivative.expiration_date: This option grant was previously reported as having an expiration date of March 31, 2027, which has been revised herein. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,463 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · derivative · entry 15 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 752 Underlying: Common Stock · 1,463 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying shares on January 1, 2018 and has vested or will vest and become exercisable with respect to the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F8 · derivative.expiration_date: This option grant was previously reported as having an expiration date of December 31, 2026, which has been revised herein. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 13 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 880 Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 12 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 880 Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 11 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 880 Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 880 Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GiftCommon Stock | 1,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,384 Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,952 | $42.15 | $82,276.80 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 12,687 | $10.38 | $131,691.06 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 22,706 | $2.07 | $47,001.42 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,628 | $0.94 | $3,410.32 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 1,463 | $0.94 | $1,375.22 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · derivative · entry 14 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,706 Underlying: Common Stock · 3,000 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. F6 · derivative.expiration_date: This option grant was previously reported as having an expiration date of May 31, 2024, which has been revised herein. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 900 | $100.20 | $90,180.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,068 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.03 to $100.53. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,100 | $99.02 | $207,942.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,968 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.96 to $99.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,000 | $2.07 | $6,210.00 |
DisclosureSEC source: 0001104659-20-085988 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 197 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 22:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-20-076939 · a4.xml · derivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,706 Underlying: Common Stock · 12,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 22:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,707 | $96.40 | $260,954.80 |
DisclosureSEC source: 0001104659-20-076939 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,871 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.25 to $96.55. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 22:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 5,198 | $97.19 | $505,193.62 |
DisclosureSEC source: 0001104659-20-076939 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,578 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.57 to $97.56. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 22:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 4,095 | $97.89 | $400,859.55 |
DisclosureSEC source: 0001104659-20-076939 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,776 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.57 to $98.56. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 22:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 12,000 | $2.07 | $24,840.00 |
DisclosureSEC source: 0001104659-20-076939 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 165 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $71.00 | $0.00 |
DisclosureSEC source: 0001104659-19-073833 · a4.xml · derivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-12-16 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 23:16 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,800 | $0.94 | $3,572.00 |
DisclosureSEC source: 0001104659-19-052723 · a4a.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: This amendment to the Form 4 originally filed on October 2, 2019 is being filed to correct the filing code in column 4 of Table I to reflect an acquisition of shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 23:16 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 9,200 | $0.94 | $8,648.00 |
DisclosureSEC source: 0001104659-19-052723 · a4a.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: This amendment to the Form 4 originally filed on October 2, 2019 is being filed to correct the filing code in column 4 of Table I to reflect an acquisition of shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 23:16 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 15,000 | $2.07 | $31,050.00 |
DisclosureSEC source: 0001104659-19-052723 · a4a.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: This amendment to the Form 4 originally filed on October 2, 2019 is being filed to correct the filing code in column 4 of Table I to reflect an acquisition of shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,800 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,215 Underlying: Common Stock · 3,800 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a right to purchase a total of 6,015 shares, vested and became exercisable as to 25% of the underlying shares on January 1, 2018 and the remaining 75% of the underlying shares have vested or will continue to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. As of September 30, 2019, the option was vested and exercisable as to 4,009 of the underlying shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,200 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · derivative · entry 9 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,589 Underlying: Common Stock · 9,200 shares Expires 2027-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 15,789 shares, vested and became exercisable as to 25% of the underlying shares on April 1, 2018, and the remaining 75% of the underlying shares have vested or will continue to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. As of September 30, 2019, the option was vested and exercisable as to 9,539 of the underlying shares. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · derivative · entry 8 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,706 Underlying: Common Stock · 15,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 3,800 | $0.94 | $3,572.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 9,200 | $0.94 | $8,648.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 15,000 | $2.07 | $31,050.00 |
DisclosureSEC source: 0001104659-19-052579 · a4.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · derivative · entry 10 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,706 Underlying: Common Stock · 4,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 200 | $64.89 | $12,978.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 700 | $65.57 | $45,899.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,906 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.22 to $65.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:28 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,200 | $66.71 | $80,052.00 |
DisclosureSEC source: 0001104659-19-046656 · a4.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,606 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.33 to $67.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.